Catalogs >
Beijing O&D Biotech Co., Ltd. >
Influenza A and B (Flu A&B) Test Kit (Colloidal Gold) 00015C

Influenza A and B (Flu A&B) Test Kit (Colloidal Gold) 00015C
5Pages

Catalog excerpts

Influenza A and B (Flu A&B) Test Kit (Colloidal Gold) 00015C - 1

O&D BIOTECH Influenza A and B (FLU A&B) Test Kit Colloidal Gold CONTACT US: Web: www.odbio.com Contact: Grace Zhang, zhangjh@odbio.com ADD: West, F4, Bld1, No.1 Shunqiang Rd, Renhe Town, Shunyi District, Beijing, China

Open the catalog to page 1

Influenza A and B (Flu A&B) Test Kit (Colloidal Gold) 00015C - 2

Influenza A and B (FLU A&B) Test Kit Colloidal Gold Easy to use, no equipment required Available with both influenza A and B controls for quality assurance A superior high sensitivity by using monoclonal antibody of influenza virus nucleoprotein (NP)

Open the catalog to page 2

Influenza A and B (Flu A&B) Test Kit (Colloidal Gold) 00015C - 3

Product Components Test cassette Extraction buffer Extraction tube Nasal swab Order Information Product Name Packing Size Sample Type Nasal swab or nasopharyngeal swab Storage Condition Shelf Life 20x Test cassettes (individually packed) 20x Extraction tubes 20x Nasal swabs 2x Extraction buffer 1x Instruction for use

Open the catalog to page 3

Influenza A and B (Flu A&B) Test Kit (Colloidal Gold) 00015C - 4

Test Procedure ① Dispense 300uL (about 13 drops) extraction buffer from the extraction buffer bottle to the extraction tube. ② Collect the sample according to the standard operation method. ③ Place the patient swab sample into the extraction tube (contains 300uL extraction buffer). Vigorously rotate and twist the swab against the side of the tube at least 10 times. ④ Leave the swab in the extraction tube for 1 minute. ⑤ Squeeze the sides of the tube to obtain as much liquid as possible. Dispose of swab properly. ⑥ Fit the dropper tip on top of the extraction tube tightly. ⑦ Add 100µL (about...

Open the catalog to page 4

Influenza A and B (Flu A&B) Test Kit (Colloidal Gold) 00015C - 5

The performance of the Influenza A/B Assay was compared to cell culture in a prospective study. 626 fresh specimens (nasopharyngeal swab) prospectively collected were tested. The results of the prospective clinical trials are given in the following tables: geal Swab Tissue Culture The assay demonstrated acceptable clinical sensitivity and clinical specificity. Compared to cell culture method, the clinical sensitivity and clinical specificity of Influenza A assay were 80.3% (95% CI: 68.7-89.1% ) and 96.6% (95% CI: 94.8-97.9%) respectively. The clinical sensitivity and clinical specificity of...

Open the catalog to page 5